SEC Form 4 · accession 0001240679-17-000017
PSYCHEMEDICS CORP · PMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael I Schaffer
Officer — VP of Laboratory Operations
Period of report
May 23, 2017
Accepted (ET)
May 25, 2017 · 3:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000806517
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.005 Par ValueF1 | May 23, 2017 | F | 580 | $21.04 | D | 42,066 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes an additional 199 Shares acquired since May 10, 2017 under the Company's Dividend Reinvestment Plan